Publications


Novel non-sulfonamide 5-HT6receptor partial inverse agonist in a group of imidazo[4,5-b]pyridines with cognition enhancing properties. David Vanda, Miroslav Soural, Vittorio Canale, Séverine Chaumont-Dubel, Grzegorz Satała, Tomasz Kos, Petr Funk, Veronika Fülöpová, Barbora Lemrová, Paulina Koczurkiewicz, Elżbieta Pękala, Andrzej J Bojarski, Piotr Popik, Philippe Marin, Paweł Zajdel
European journal of medicinal chemistry, S0223-5234(17)31084-X 10.1016/j.ejmech.2017.12.053
PMID:29291439

Saturday, 16 December 2017
Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile. Vittorio Canale, Anna Partyka, Rafał Kurczab, Martyna Krawczyk, Tomasz Kos, Grzegorz Satała, Bartłomiej Kubica, Magdalena Jastrzębska-Więsek, Anna Wesołowska, Andrzej J Bojarski, Piotr Popik, Paweł Zajdel
Bioorganic & medicinal chemistry, S0968-0896(17)30359-0 10.1016/j.bmc.2017.03.057
PMID:28391970

Wednesday, 29 March 2017
Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats. Agnieszka Potasiewicz, Agnieszka Nikiforuk, Małgorzata Hołuj, Piotr Popik
Journal of psychopharmacology (Oxford, England), 10.1177/0269881116675509
PMID:28168926

Tuesday, 15 November 2016
3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats. Agnieszka Potasiewicz, Małgorzata Hołuj, Tomasz Kos, Piotr Popik, Hugo R Arias, Agnieszka Nikiforuk
Neuropharmacology, S0028-3908(16)30450-6 10.1016/j.neuropharm.2016.10.002
PMID:27717880

Tuesday, 4 October 2016
The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors. Agnieszka Nikiforuk, Agnieszka Potasiewicz, Tomasz Kos, Piotr Popik
Behavioural brain research, 10.1016/j.bbr.2016.07.023 S0166-4328(16)30451-X
PMID:27435422

Monday, 18 July 2016
The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia. Agnieszka Nikiforuk, Małgorzata Hołuj, Tomasz Kos, Piotr Popik
Neuropharmacology, 10.1016/j.neuropharm.2016.01.035 S0028-3908(16)30034-X
PMID:26826431

Thursday, 19 May 2016
N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties. Paweł Zajdel, Krzysztof Marciniec, Grzegorz Satała, Vittorio Canale, Tomasz Kos, Anna Partyka, Magdalena Jastrzębska-Więsek, Anna Wesołowska, Agnieszka Basińska-Ziobroń, Jacek Wójcikowski, Władysława A Daniel, Andrzej J Bojarski, Piotr Popik
ACS medicinal chemistry letters, 10.1021/acsmedchemlett.6b00056
PMID:27326337

Thursday, 7 April 2016
The effects of PDE10 inhibition on attentional set-shifting do not depend on the activation of dopamine D1 receptors. Agnieszka Nikiforuk, Agnieszka Potasiewicz, Dominik Rafa, Karla Drescher, Anton Bespalov, Piotr Popik
Behavioural pharmacology, 10.1097/FBP.0000000000000201
PMID:26580130

Wednesday, 18 November 2015
Anandamide mediates cognitive judgement bias in rats. J Kregiel, N Malek, P Popik, K Starowicz, R Rygula
Neuropharmacology, S0028-3908(15)30101-5 10.1016/j.neuropharm.2015.09.009
PMID:26363193

Monday, 9 November 2015
Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats. Agnieszka Nikiforuk, Tomasz Kos, Małgorzata Hołuj, Agnieszka Potasiewicz, Piotr Popik
Neuropharmacology, S0028-3908(15)30041-1 10.1016/j.neuropharm.2015.07.034
PMID:26232639

Monday, 9 November 2015